Platelets are critical for the maintenance of the integrity of the Vascular
system and are the first line of defence against haemorrhage. When they en
counter a subendothelial matrix exposed by injury to a vessel, platelets ad
here, are activated, anti become adhesive fur other platelets so chat they
aggregate. alpha IIb/beta 3, a platelet-specific integrin, is largely promi
nent amongst the adhesion receptors and is essential for platelet aggregati
on. The ligands for alpha IIb/beta 3 are the multivalent adhesive proteins
fibrinogen and von Willebrand factor. In resting platelets, alpha IIb/beta
3 is normally in a low activation state, unable to interact with soluble fi
brinogen. Stimulation of platelets with various agonists will induce a conf
ormational change in alpha IIb/beta 3 (inside-out signalling). which is the
n able to bind soluble fibrinogen resulting in the onset of platelet aggreg
ation. However, fibrinogen binding to its membrane receptor is nor simply a
passive event allowing the formation of intercellular bridges between plat
elets. Indeed, a complex signalling pathway triggered by integrin ligation
and clustering (outside-in signalling) will regulate the extent of irrevers
ible platelet aggregation and clot retraction. Amongst the signalling enzym
es activated downstream of alpha IIb/beta 3 engagement, phosphoinositide 3-
kinase plays an important role in the control of the irreversible phase of
aggregation. BIOCHEM PHARMACOL 60;8:1069-1074, 2000. (C) 2000 Elsevier Scie
nce Inc.